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Maintenance of neonatal circulatory homeostasis is a real challenge, due to the complex 
physiology during postnatal transition and the inherent immaturity of the cardiovascular 
system and other relevant organs. It is known that abnormal cardiovascular function 
during the neonatal period is associated with increased risk of severe morbidity and 
mortality. Understanding the functional and structural characteristics of the neonatal 
circulation is, therefore, essential, as therapeutic hemodynamic interventions should be 
based on the assumed underlying (patho)physiology. The clinical assessment of systemic 
blood flow (SBF) by indirect parameters, such as blood pressure, capillary refill time, 
heart rate, urine output, and central-peripheral temperature difference is inaccurate. As 
blood pressure is no surrogate for SBF, information on cardiac output and systemic 
vascular resistance should be obtained in combination with an evaluation of end organ 
perfusion. Accurate and reliable hemodynamic monitoring systems are required to 
detect inadequate tissue perfusion and oxygenation at an early stage before this result in 
irreversible damage. Also, the hemodynamic response to the initiated treatment should 
be re-evaluated regularly as changes in cardiovascular function can occur quickly. New 
insights in the understanding of neonatal cardiovascular physiology are reviewed and 
several methods for current and future neonatal hemodynamic monitoring are discussed.
Keywords: neonate, hemodynamics, developmental physiology, cardiac output, hemodynamic monitoring, 
preterm infant
iNTRODUCTiON
Every day, neonatologists continually struggle to determine hemodynamic instability in their patients 
(does normal blood pressure guarantee an adequate perfusion and oxygen delivery?), to decide to 
initiate treatment (should every patient with hypotension be treated or is permissive hypotension an 
option?) and if so, which therapy is the best for this individual patient (inotropes, vasopressors or 
fluid administration)? Many of these questions remain unanswered: most of the current treatment 
modalities and guidelines are based on expert opinion rather than on evidence, as clinical trials in 
neonates are challenging due to clinical, methodological, and ethical issues (1). Clinical assessment 
of hemodynamic compromise is proven to be inaccurate and adequate monitoring systems are war-
ranted (2). The main goals of hemodynamic monitoring are (1) recognition of early (compensated) 
stage of shock as further progression to uncompensated shock will result in increased morbidity 
and mortality (3–5), (2) timely initiation of targeted therapy, (3) evaluation of the response to the 
initiated interventions, and (4) gain of insight in the developmental cardiovascular physiology to 
improve treatment strategies.
FigURe 1 | Relationship between oxygen delivery and oxygen consumption. VO2, oxygen consumption; DO2, oxygen delivery; SvO2, (mixed) venous oxygen 
saturation; OER, oxygen extraction ratio. X-axis shows the gradual decrease in DO2 with the lowest DO2 on the right side of the figure; Light gray area: VO2 = DO2 
independent; Dark gray area: VO2 = DO2 dependent.
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The neonatal circulation functionally distinguishes itself from 
the pediatric and adult circulation in many ways as the newborn 
population is a rather heterogeneous group with a wide range in 
gestational and postnatal ages, all with different levels of maturation 
of the cardiovascular system. Understanding of fetal and neonatal 
cardiovascular (patho)physiology is warranted in order to recognize 
hemodynamic instability in time. The developing cardiovascular 
system undergoes significant functional alterations in preload, 
contractility, afterload, diastolic filling, and intra-cardiac flow pat-
terns compared to the circulation later in life (6). Besides knowledge 
of the immature function, insight in the dynamic changes during 
transition from fetal to neonatal life is mandatory (7). Especially 
in preterm infants, who are still developing their cardiovascular 
system, a normal fetal condition can become pathological several 
hours later in postnatal life. Furthermore, treatment decisions for 
many common clinical presentations of the (pre)term infant, such 
as sepsis, persistent pulmonary hypertension, asphyxia, and patent 
ductus arteriosus rely on applying knowledge of physiology and 
pathophysiology to identify optimal therapy. Adequate circulation 
can be defined as an adequate balance between oxygen delivery and 
oxygen consumption on both systemic and regional level. For an 
accurate circulatory assessment, monitoring of both the macro- and 
microcirculation is, therefore, essential.
Our objective is to review new insights in the understanding of 
transitional cardiovascular physiology and discuss available meth-
ods for current and future neonatal cardiovascular monitoring.
DeveLOPMeNTAL CARDiOvASCULAR 
PHYSiOLOgY
Oxygen Delivery and Consumption
The primary goal of blood flow is to deliver oxygen and nutrients 
to the cells to meet their metabolic demands and to remove car-
bon dioxide and waste products. There is a complex interaction 
between blood pressure, systemic blood flow (SBF), and systemic 
vascular resistance (SVR), which is regulated by the autonomic 
central nervous system (medulla oblongata), the peripheral 
nervous system, the cardiovascular system (baroreceptors and 
chemoreceptors), and endocrine mechanisms (8).
The amount of oxygen required by the tissue depends on the 
functional state of the cells. Furthermore, certain organs—the 
brain, heart, adrenal glands, and renal cortex—have persistently 
high oxygen demands, while other organs like the spleen and 
the skin can suffice with a lower oxygen supply. The gastroin-
testinal tract and skeletal muscles have variable oxygen needs. 
Neuro-endocrine and local vascular mechanisms regulate tissue 
perfusion in the compensated phase of shock. Blood flow toward 
vital organs (via high-priority vessels) is then preserved by local 
vasodilatation, while the vasculature of non-vital organs (via low 
priority vessels) tends to constrict in order to redistribute the 
blood mainly from the splanchnic vasculature. The latter might be 
a predisposing factor for the development of necrotic enterocolitis. 
During this phase, normal blood pressure is preserved. When this 
compensatory mechanism fails, hypotension will occur and organ 
blood flow further diminishes resulting in dysoxia and eventually 
cell death. Unless treated early, circulatory failure will result in 
organ failure and an increased risk of mortality and morbidity. 
Except for changes in oxygen levels, chemoreceptors are also 
senstitive to changes in blood carbon dioxide levels, resulting in 
local blood flow changes. Especially in critically ill ventilated (pre-
term) infants prevention of hyper- and hypocapnia is essential 
as hypercapnia can lead to cerebral hyperperfusion, while a low 
carbon dioxide level potentially decreases cerebral blood flow.
The relationship between tissue oxygen delivery and oxygen 
consumption (VO2) is biphasic as shown in Figure 1 (9, 10). Under 
normal circumstances, DO2 outweighs VO2. An increase in VO2 
will be compensated by an increase in pulmonary oxygen uptake 
in patients with healthy lungs. In this circumstance, VO2 can be 
doubled without an increase in cardiac output (CO). In critically 
ill neonates with (respiratory and) cardiovascular compromise, 
a decrease in DO2 is compensated by an increase in oxygen 
FigURe 2 | The neonatal circulation. RVO, right ventricular output; PBF pulmonary blood flow; LVO, left ventricular output; AAo, blood flow in ascending aorta; DAo, 
blood flow in descending aorta; DA, ductus arteriosus; VCS, vena cava superior; VCI, vena cava inferior; VR, venous return.
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extraction enabling the preservation of the level of VO2 (phase 1). 
The increase in oxygen extraction is believed to be the result of 
recruitment of the capillaries, thereby increasing the surface for 
passive oxygen diffusion. In this way, the oxygen extraction can be 
augmented from ±30% under normal circumstances to 50–60% 
when oxygen delivery is limited. These compensatory mechanisms 
are very important in critically ill newborn infants. However, it 
should be noted that it has been shown in animal studies as well 
as in growth-restricted fetuses and preterm infants that the high-
priority vascular assignment of the forebrain is incomplete at birth 
and, therefore, responds with vasoconstriction when perfusion is 
decreased (11–14). At some critical point, this oxygen extraction 
ratio—defined as VO2/DO2—is maximal and a further decrease in 
oxygen delivery will result in a decrease in oxygen availability and, 
therefore, consumption oxygen (oxygen delivery-dependency) 
(phase 2), leading to anaerobic metabolism. The threshold for 
anaerobic metabolism probably occurs at SmVO2 <40%.
Feto-Neonatal Cardiovascular Transition
During fetal life the circulation can be characterized by two parallel 
circuits with equal left and right ventricle pressures, right ventri-
cle predominance around 55% of combined CO, a low-resistance 
placental circulation, and the presence of shunts. Fetal animal and 
human studies have shown that—depending on gestational age—
almost half of the total CO flows into the placenta resulting in 
the same amount of venous return (VR) from this low-resistance 
system. The umbilical venous blood passes through the ductus 
venosus after it has mixed with a small amount of blood from the 
portal vein. Most of the oxygenated blood in the right atrium is 
then diverted through the foramen ovale (FO) to the direction 
of the left atrium and left ventricle, where it is being ejected into 
the ascending aorta supplying the head and neck vessels together 
with pulmonary venous blood. The deoxygenated blood from the 
superior and inferior vena cava (IVC) is preferentially directed 
to the right ventricle, from which 75–90% of the output is then 
shunted through the ductus arteriosus into the descending 
aorta toward the rest of the body due to the higher pulmonary 
vascular resistance (PVR) in relation to a relatively low SVR (15, 
16). Only a small portion of blood volume perfuses the lungs. 
With advancing gestation, changes in umbilical flow, placental 
perfusion, PVR, and hence pulmonary blood flow (PBF) occur, 
leading to a highest level of PBF around 30 weeks of gestation 
(17). Umbilical cord clamping at delivery is followed by major 
cardiovascular changes within seconds and hours, although the 
final transition only finalizes within weeks. The instant loss of the 
low-resistance, high-flow placental bed results in an increase in 
SVR, and a 30–50% decrease in VR affecting CO. With the onset of 
ventilation, PVR decreases and PBF increases followed by a rise in 
pulmonary VR and left atrial pressure resulting in the functional 
closure of the FO and completing the transition from a parallel to 
a serial circulation. Animal and neonatal studies have shown that 
after an elective caesarian section, transductal blood flow changes 
from predominantly right-to-left to predominantly left-to-right 
within 10 min after birth, reflecting the instant changes in both 
systemic and PVR (18, 19). The ductus venosus remains patent 
for several days without any circulatory consequences (20). 
Further completion of the transition is finalized by closure of the 
ductus arteriosus, which is established by multiple mechanisms, 
including an increase in arterial oxygen content, decreased 
prostaglandin levels, expression of endothelin I and its receptors, 
and an increase in catecholamines (21, 22). The initial functional 
closure of the ductus usually occurs within a few hours after birth 
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due to smooth muscle contraction, while the anatomical closure 
with remodeling of the intima and loss of smooth muscle in the 
media might take several weeks or even months, especially in 
preterm infants (23). The FO can remain patent for some years. 
The neonatal circulation after birth is shown in Figure 2. Intrinsic 
and external factors can influence the transition process result-
ing in sustained increased vascular pulmonary resistance with 
persistent right-to-left shunt. In contrast, the gradually fall in 
PVR in combination with a higher SVR will result in left-to-right 
shunting when the ductus arteriosus remains patent (PDA). The 
incidence of a PDA correlates inversely with gestational age and 
weight and might increase to >50% in preterm infants weighting 
500–750 g (24). A persistent patent ductus arteriosus seems to be 
associated with increased morbidity possibly due to pulmonary 
overflow in combination with decreased SBF (3, 25, 26). After 
many years and many non-conclusive trials, we are still not sure 
whether or when to treat the preterm infant with PDA (27, 28).
Determinants of CO and Oxygen Delivery
Maintaining an optimal balance between oxygen delivery and 
oxygen consumption is a challenge in the transitional period and 
beyond. Oxygen delivery is determined by CO and the arterial 
oxygen content (DO2 = CO × caO2); global oxygen consumption 
can be calculated by multiplying the CO by the difference between 
arterial and mixed venous oxygen content (VO2 = CO × c(a-mv)O2). 
In turn, arterial and mixed venous oxygen content are function 
of arterial and mixed venous oxygen saturation, arterial and 
venous partial oxygen pressure, and hemoglobin concentration: 
oxygen content cO2  =  (Hb [mmol/L]  ×  0.98 [L O2/mmol/L 
Hb] × SO2/100) + (0.0004 × PO2 [kPa]).
Cardiac output is a major determinant of oxygen delivery and 
is defined as the product of heart rate (HR) and stroke volume 
(SV). SV is determined by preload, contractility, and afterload, all 
parameters which are intertwined. During the transitional phase, 
substantial changes occur in preload, myocardial contractility, 
and pulmonary/SVR and flow. Especially in preterm infants with 
an immature cardiovascular system, adaptation to these changes 
can be difficult.
SV and HR
For a long time, it was assumed that neonates can only increase 
their CO by increasing HR, while SV remains relatively fixed. 
However, several studies have shown that in term neonates 
during and after transition left ventricular SV and output (LVO) 
increases, whereas blood pressure and HR remains stable or 
decreases. These changes are presumably due to an increase in 
LV preload as a result of higher PBF in combination with ductal 
left-to-right shunting (29–31). Also, in term newborns with 
hypovolemic or cardiogenic shock, changes in LVO after volume 
replacement are mainly determined by changes in SV and not HR 
(32). Several studies indicate that changes in SBF in preterm infants 
are mainly the result of changes in SV rather than alterations in 
HR (4, 33, 34). With novel echocardiographic techniques, such 
as speckle tracking imaging, these findings have been confirmed 
(35). Furthermore, the preterm circulation is characterized by an 
intrinsic diastolic dysfunction and high resting HR levels result-
ing in a limited ability to increase CO by just increasing HR. 
Moreover, a rise in HR will shorten the end-diastolic ventricular 
filling time, decreasing SV and, therefore, attenuates CO. Most of 
the inotropic agents used for the treatment of circulatory failure 
also have chronotropic properties, partially counteracting their 
intended effect. In adult intensive care, trials with β-blockade 
(e.g., esmolol) have been shown to be beneficial in reducing HR, 
enhancing cardiac function, and reducing the need for vasopres-
sors in septic patients after the initial phase of hypovolemia (36, 
37). In analogy with adults, it might also be favorable to reduce 
HRs in tachycardic newborns to optimize SV and in addition CO. 
This treatment option needs further research.
Contractility
Contractility refers to the ability of myocytes to change their 
contractile force independent of preload. Due to myocardial 
immaturity, both morphologically and functionally, the fetus 
and neonate have a limited capacity to increase contractility 
(38). The immature myocardium is characterized by a lower 
number of myofibrils per cross-sectional area (CSA) with a 
simplified internal organization, immaturity of the sarcoplas-
matic reticulum and T tubules, altered calcium handling, lower 
troponin C levels, and higher troponin T levels, all leading to 
less force during contraction (39–41). Furthermore, contractility 
is impaired as a result of a decreased number of β-adrenergic 
receptors and less sympathic innervations. The increase in 
contractile force (secondary to an increase in calcium influx) is 
age dependent and improves during the early postnatal period. 
Schiffmann studied the myocardial function in the developing 
rabbit heart and demonstrated a significant increase in contrac-
tility (45%) and relaxation (75%) within the first 8 postnatal 
days. Administration of increasing dosages of inotropes, such 
as isoproterenol and ouabain, had (significantly) lesser effect on 
both myocardial contractility and relaxation in neonatal hearts 
in comparison to adult hearts (42). The muscle fibers of the adult 
myocardium are organized in such a way that the squeeze of 
blood into the outflow tract is optimized: the apex rotates in a 
counter-clockwise direction to the base, while the other fibers 
move in the opposite direction to enhance the torsion/outflow. 
In preterm infants <29  weeks, James et  al. found that apical 
rotation (counter-clockwise) remained constant over the first 
week, while basal rotation changed from counter-clockwise to 
clockwise using two-dimensional speckle-tracking echocardi-
ography, suggesting changes in LV rotational physiology (43). 
Impaired myocardial function is often seen in neonates with 
asphyxia, preterm infants after ductus ligation, and newborns 
with (congenital) cardiomyopathy.
Preload
The relationship between preload and SV is shown by the Frank–
Starling (FS) curve (Figure 3). Preload refers to the ability of the 
heart to change its force of contraction—and, therefore, SV—in 
response to changes in the volume of blood entering the heart 
when all other factors remain constant. It is the initial stretching 
of the cardiac muscle fibers prior to contraction (mostly referred 
to as end-diastolic ventricular volume). Preload is determined 
by VR (and, therefore, the circulating volume and the venous 
capacitance) and ventricular compliance.
FigURe 3 | Schematic representation of the Frank–Starling curve. 1 = adult 
cardiac function; 2 = fetal/neonatal cardiac function. A similar change in 
preload will result in a larger increase in cardiac output/stroke volume in 
adults than in neonates.
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Compliance
The compliance describes the change in volume as a result of 
a change in pressure and depends on the structural properties 
of the cardiac muscle. The alteration in cardiac compliance 
from fetal to adult life is not yet fully understood. Early stud-
ies suggested that fetal cardiac compliance is rather low with a 
developmental increase in compliance during gestation (39). In 
contrast, more recent studies have shown that the fetal heart has 
a higher compliance compared to the adult heart due to the pres-
ence of specific fetal connectin isoforms (6, 44). Connectin is a 
protein that links the z-disk of the tin filament to the myosin thick 
filament. The fetal isoform has high elastic properties, leading to 
a reduced myocardial stiffness and a low passive tension. These 
characteristics allow the fetal myocardium to generate adequate 
CO despite low filling pressures in utero.
Ventricular Filling and VR
Ventricular filling is characterized by an early “passive” phase 
followed by an active phase, secondary to atrial contraction 
(E-wave and A-wave, respectively on Doppler echocardiogra-
phy). The passive phase predominates in adults, children, and 
healty term newborns leading to an E/A-ratio >1. In contrast, in 
fetal diastole the active phase is more pronounced leading to an 
inverse E/A-ratio of <1 (45). This less passive filling is influenced 
by multiple factors, e.g., (1) low pulmonary VR to the left atrium 
due to limited PBF, so LV filling volumes mainly depend on blood 
flow through the FO and (2) the altered compliance: previously, 
the impaired passive filling was attributed to the lower compli-
ance with increased myocardial stiffness. However, as already 
mentioned above, it can be argued that also the high compliant 
fetal heart might have a lower passive filling phase: the force 
generated by the connectin protein when restoring its so-called 
resting length after systolic contraction or diastolic distention will 
decrease with higher compliance (46). At early diastole, when 
blood is effectively suctioned into the ventricles as a result of 
negative pressure generated by sarcomeres restoring their resting 
length after systolic contraction (the ventricular untwist), the 
fetal myocardium will generate less force leading to less passive 
filling and, therefore, a lower E/A ratio.
Throughout gestation the E/A-ratio over the mitral valve will 
increase (but rarely exceeds >1) as the pulmonary VR (PBF) 
will increase (peak around 30 weeks of gestation), a process that 
continues after birth. Immediate cord clamping after birth leads 
to an increase in SVR and a decrease in VR resulting in a low 
LVO. LV preload will then be restored as a result of an increase 
of PBF in combination with a decrease in pericardial pressure 
when negative intrapleural pressure and lung expansion occurs, 
leading to a less restrictive ventricular filling pattern (47). The 
initial drop in LVO can partly be avoided if ventilation already 
commences before the cord is clamped, since then there will be 
no loss in preload as VR immediately switches from umbilical to 
pulmonary VR upon cord clamping. Initiating ventilation before 
cord clamping can, therefore, mitigate the changes in CO (7). In 
addition, delayed cord clamping is associated with other benefits, 
such as increased circulating volume, decreased incidence of late-
onset sepsis and intracranial hemorrhage, and a reduced need for 
transfusions (48).
Circulating Blood Volume
Acute blood loss due to perinatal events (feto-maternal transfu-
sion, placental abruption), extensive insensible water loss or 
capillary leak in patients with sepsis, and necrotizing enterocolitis 
are potential causes of low circulating blood volume resulting in 
a reduced preload and subsequently ventricular dysfunction. 
In contrast, (abundant) fluid administration might also impair 
ventricular function and CO as the heart functions near or on the 
flat part of the FS curve (Figure 3).
Venous Capacitance and Mean Systemic Filling Pressure (Pmsf)
The veins contain about 65% of the total blood volume. They are 
much more compliant than arteries, especially the splanchnic and 
cutaneous venous beds which have high concentrations of α1- and 
α2-adrenergic receptors and, therefore, sensitive to adrenergic 
stimulation. The venous system serves as a blood reservoir adjust-
able to blood flow requirements. As blood flows from the aorta into 
the systemic circulation, and subsequently returns via the veins, 
intravascular pressure will drop gradually to the level of the right 
atrium pressure (RAP). The Pmsf is defined as the equilibrating 
pressure across the circulatory system during circulatory arrest. 
Under normal conditions there is one point (the pivot point) where 
the intravascular pressure equals the Pmsf. The Pmsf provides, 
therefore, a quantitative measurement of the filling status.
The volume that is required to fill the vasculature without 
increasing the transmural pressure is called the unstressed volume 
(Figure 4). The stressed volume (VS) is any amount of volume 
that leads to an increase in transmural pressure, when added 
to the unstressed volume. Mathematically Pmsf is calculated 
as the VS divided by the compliance (C) of the venous system 
[Pmsf = VS/C]. As the driving force for blood flow is supplied 
by a pressure gradient and determined by the resistance to flow 
(Hagen–Poiseuille’s law), the VR—which must equal CO—can be 
calculated by the difference between the Pmsf and RAP divided 
FigURe 4 | Intravascular volumes and pressure in the venous compartment. 
Green interrupted line = Pmsf mean systemic filling pressure; dark blue 
box = unstressed volume = that volume which is required to fill the 
vasculature without increase in transmural pressure; light blue box = stressed 
volume = any amount of volume added to the unstressed volume that leads 
to an increase in transmural pressure.
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by the resistance (Rven) to VR [VR =  (Pmsf −  RAP)/Rven]. VR 
is influenced by total blood volume, compliance of the venous 
system, and the administration of inotropes/vasopressors (49). 
In addition, changes in VR will reflect on ventricular function, 
since CO showed equal cardiac input. Reports on the use and 
measurement of Pmsf are scarce in neonates (50).
Afterload
Afterload is defined as the force against which the heart must 
act in order to pump the SV and largely depends on ventricular 
dimensions, blood pressure, (systemic) vascular resistance, and 
vascular compliance. Morphologically, it is the tension experi-
enced by each sarcomere unit. The terms afterload and ventricu-
lar wall stress are related, however, not interchangeable, as can be 
understood from Lamé’s equation.
 
σ
δ
∝
P r
h
T
h
��
�
×
=
 
(σ =  ventricular wall stress, δP =  ventricular transmural 
pressure, r = ventricular radius, h = ventricular wall thickness, 
and T = ventricular wall tension). With increasing afterload, the 
ventricular wall stress increases and the echocardiographically 
derived velocity of circumferential fiber shortening decreases 
resulting in a decrease in SV. The rate-corrected mean velocity 
of circumferential fiber shortening (mVcfc)—end-systolic wall 
stress (ESS) relation is used to measure ventricular performance, 
adjusting for the influence of afterload, but independent of 
preload and HR. Echocardiographic studies have shown that 
there is an age-dependent mVcfc-ESS relationship suggesting 
that newborns have a higher basal contractile state and that myo-
cardial performance is more sensitive to afterload in the imma-
ture heart (51, 52). With preload—afterload interdependence, 
the negative effect on SV caused by an increase in afterload can 
partly be compensated by an increase in left atrial pressure, 
enhancing contractility. High afterload can be observed in 
neonates shortly after transition, after ductal ligation, and in the 
presence of cold shock (low CO and high SVR). Low afterload 
as a result of low vascular tone/SVR is a cause of circulatory 
failure in neonates with warm shock (high CO and low SVR). 
It is important to differentiate between these different presenta-
tions of shock, as they require other therapeutic approaches 
(inotropes versus vasopressors) (53–56).
Central Venous Oxygen Saturation
Mixed venous oxygen saturation (SmvO2) represents the 
oxygen reserve after tissue oxygen extraction. Under normal 
conditions the body extracts approximately 25–30% of oxy-
gen from the arterial blood resulting in a SmvO2 of 70–75%. 
Assuming stable hemoglobin and SaO2 levels, a decrease in 
SmvO2 is either the result of an increase in oxygen consump-
tion (stress, pain, seizures, or increased metabolic demand 
in case of sepsis), or a decrease in CO. Mixed venous oxygen 
saturation can only be measured from blood sampled from the 
main pulmonary artery, which is not feasible in neonates. An 
alternative is to sample venous blood from the right atrium 
or the caval veins (depending on the position of the central 
venous catheter)—central venous oxygen saturation (ScvO2). 
However, absolute values of SmvO2 and ScvO2 are not inter-
changeable for various reasons (57, 58). ScvO2 is among others 
influenced by (1) sampling site differences: under normal 
physiologic circumstances vena cava inferior oxygen saturation 
(SivcO2) is higher than vena cava superior oxygen saturation 
(SsvcO2) (the gut being a low oxygen extraction organ) with 
the latter being lower than the mixed venous oxygen satura-
tion. During shock, as a result of redistribution phenomena, 
the relationship between the SsvcO2 and the SmvO2 might be 
reversed; (2) the presence of a (intracardiac) left-to-right shunt 
(which increases the SmvO2, but not SsvcO2); (3) incomplete 
mixing of blood: sampling blood from the superior or IVC 
might contribute to the higher values compared to SmvO2 as 
this latter also includes unsaturated blood from the coronary 
arteries; (4) redistribution of blood flow during shock: as 
cerebral blood flow and oxygenation is usually preserved over 
some period of shock, the drop in SsvcO2 is less marked and 
delayed compared to the drop in SmvO2. In contrast, due to 
redistribution and an increase in oxygen extraction in the 
splanchnic vascular bed, the SivcO2 will underestimate SmvO2; 
(5) the level of consciousness: restlessness can increase oxygen 
consumption and, therefore, decrease SmvO2, while (over)use 
of sedatives will have the opposite effect. Therapeutic cooling 
will also increase SmvO2; and (6) myocardial oxygen consump-
tion can influence measurements of SmvO2. Despite these dif-
ferences, absolute changes of SmvO2 and ScvO2 occur mostly 
in a parallel manner. While decreasing values of SvO2 mostly 
reflect inadequate oxygen delivery or increased consumption, 
normal or high values cannot be interpreted as normal tissue 
oxygenation. Especially in septic and circulatory compromised 
patients, SvO2 might be high due to mitochondrial dysfunction 
with impaired oxygen extraction.
FigURe 5 | Relationship between PVR and lung volume. RV residual volume; FRC, functional residual capacity; TLC, total lung capacity; PVR, pulmonary vascular 
resistance; blue zone lowest pulmonary vascular resistance.
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Cardiopulmonary Interactions
As described earlier, major changes in blood flow and blood 
pressure occur during normal transition. Sick newborns and 
especially preterm infants who have reduced respiratory drive, 
poor lung compliance, and reduced thoracic musculature, often 
require positive pressure ventilation (immediately) after birth, 
adversely affecting cardiovascular function in different ways 
(59). Increasing airway pressure decreases the alveolar/capillary 
transmural pressure gradient, squeezing blood out of the intra-
alveolar capillaries, resulting in an increase in PVR and a decrease 
in PBF (Figure 5). As the LV function is highly dependent on 
preload, a reduction in pulmonary VR will reduce LV output. 
Persistent increases in airway pressure and subsequently PVR 
may even potentiate the persistence of a possible right-to-left 
shunting through the ductus arteriosus. Furthermore, a direct 
compressive effect of the positive airway pressure on the heart 
hampers the LV function and reduces CO. Inadequate ventilation 
strategies might not only impair cardiovascular function and 
SBF, but also influence cerebral blood flow in several ways, espe-
cially in preterm infants with impaired cerebral autoregulation: 
high positive end expiratory pressures can cause a significant 
reduction in CO and similarly in superior vena cava blood flow 
(representing also blood returning from the brain); ventilation 
with high tidal volumes shortly after birth results in large fluctua-
tions in cerebral blood flow and increased vascular extravasation 
(60, 61). These changes in cerebral blood flow and oxygenation 
are associated with an increased risk of intraventricular hemor-
rhage and long-term neurodevelopmental disability or death (62, 
63). As caution is warranted when using high airway pressures, 
ventilating newborns can also have beneficial hemodynamic 
effects, such as a reduction in LV afterload secondary to higher 
intrathoracic pressure, enhancing CO and oxygen delivery to the 
tissues. Moreover, decreasing work of breathing results in a lower 
metabolic demand and thereby increasing SmvO2.
HeMODYNAMiC MONiTORiNg SYSTeMS
Continuous assessment of blood pressure, HR, and arterial oxygen 
saturation alone will not provide sufficient information to initiate 
or adapt cardiovascular interventions. Hypotension can indeed 
reflect high or low SBF depending on the level of SVR and oxygen 
delivery might be impaired despite normal blood pressure in the 
phase of compensated shock. Moreover, in the preterm infant, there 
is a tendency to accept lower blood pressure (permissive hypoten-
sion) in the absence of other signs of circulatory failure (64). The 
choice of treatment in the presence of hypotension can only be 
determined when additional information is gathered on cardiac 
function, as vasopressors and inotropes influence SBF and blood 
pressure in different ways. Simultaneously, bedside measurements 
of blood pressure, blood flow, and hence SVR in combination with 
end organ perfusion are, therefore, required to adequately monitor 
changes in cardiovascular function before and after therapeutic 
interventions. An overview of different methods of hemodynamic 
monitoring systems in neonatal care is shown in Table 1.
Methods for Measuring SBF (CO)
Cardiac output is one of the major determinants of oxygen 
delivery and should, therefore, be monitored continuously or at 
TABLe 1 | Advanced hemodynamic monitoring in neonates.
Assessment of CO and intravascular volume
Method Hemodynamic 
variables
Limitations invasiveness 
and monitoring 
frequency
Applicability
Neonatologist 
performed 
echocardiography 
(NPE)
CO, vena cava 
superior flow, shunts, 
structural and functional 
abnormalities
Left ventricular end-
diastolic volume
Vena cava collapsibility
Intensive training
Intra-/interobserver variability 20%
Error in assessment of VTI (angle of insonation) and CSA
Non-invasive
Intermittent
Clinical use (absolute 
values of CO)
Preload assessment 
limited for clinical use
Transcutaneous 
doppler (USCOM®)
CO Large interobserver variability
Error in assessment of VTI (angle of insonation) and CSA
No anatomical verification of sample area
Low precision
Non-invasive
Intermittent
Limited clinical use 
(trend monitoring)
Thoracic electrical 
bio-impedance 
(ICON®, NICOM®)
CO Influenced by position of surface electrodes, changes in tissue water 
content (pulmonary edema, pleural effusion), alterations in heart rate and 
motion artifacts
Non-invasive
Continuous
Clinical use (trend 
monitoring)
Arterial pulse contour 
analysis (APCA)
CO
PPV, SVV, HRV
Influenced by changes in vascular compliance, vasomotor tone, 
medication, irregular heart rate, and motion artifacts
Influenced by physiological aliasing
Frequent calibration necessary
Invasive
Continuous
Research setting
Research setting
TPTD CO
Hemodynamic volumes 
(GEDV, ITV)
Use of ice-cold saline
Thermistor-tipped catheter needed
Arterial (femoral) and central venous catheter needed
Fluid overload after multiple injections
Invasive
Continuous
Only >3 kg
Research setting
TPUD CO, shunt detection and 
quantification
Continuous CO
Hemodynamic volumes 
(TEDV, CBV, ACV)
EVLW
Arterial and central venous catheter needed
Risk of fluid overload after multiple injections
Invasive
Intermittent
Continuous 
measurement 
possible (APCA)
Clinical use (absolute 
values of CO)
APCA as trend 
monitoring
Research setting
Stop flow method Mean systemic filling 
pressure
Venous and arterial access in the same extremity
Influenced by physiological factors (higher thoracic and arterial compliance 
and low tidal volumes compared to adults) and physiological aliasing
Invasive
Intermittent
Research setting
Plethysmograph 
variability index
Perfusion index
Fluid responsiveness
Non-invasive
Continuous
Research setting
Assessment of organ perfusion and oxygen delivery
Laser doppler 
flowmetry
Microcirculation  
(flow velocity)
Signal processing limitations
Calibration problems
Motion artifacts and probe pressure effects
Influenced by skin temperature and vasopressors
Non-invasive
Intermittent
Research setting
OPS, SDF, IDF Microcirculation Signal processing limitations (time-consuming)
Effects of probe pressure
Influenced by skin temperature, hemoglobin levels, and vasopressors
Non-invasive
Intermittent
Research setting
NIRS Regional blood 
flow, regional tissue 
oxygenation, and 
fractional tissue 
extraction
Lack of validation
Considerable probe bias
Different methods with different mathematical models
Multiple assumptions
Accuracy and precision questionable
Non-invasive
Continuous
Clinical use (trend 
monitoring)
CO, cardiac output; VTI, velocity-time integral; CSA, cross-sectional area; PPV, pulse pressure variation; SVV, stroke volume variation; HRV, heart rate variability; TPTD, 
transpulmonary thermodilution; GEDV, global end-diastolic blood volume; ITBV, intrathoracic blood volume; TPUD, transpulmonary ultrasound dilution; TEDV, total end-diastolic 
volume; CBV, central blood volume; ACV, active circulating volume, EVLW, extra vascular lung water; OPS, orthogonal polarization spectral; SDF, sidestream darkfield imaging;  
IDF, incident dark field imaging; NIRS, near infrared spectroscopy.
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least on a regular basis. Preferably, neonatal CO monitor devices 
should fulfill the following clinically important conditions: they 
are expected to (1) be validated against a gold standard reference 
method and to be accurate and precise; (2) be easy applicable 
(bedside), non-invasive, practical, and inexpensive; (3) provide 
continuous information which is easy to interpret; and (4) be 
reliable during transition and in the presence of shunts (65). It 
might be clear that such an ideal monitoring system does not 
exist. In the past decades, many techniques have become avail-
able for the measurement of CO, based on different techniques 
like Doppler ultrasound, indicator dilution, and bio-impedance. 
However, many of these are not applicable in (preterm) neonates 
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for various reasons, such as size restraints, need for dedicated 
catheters, and the inability to estimate CO in the presence 
of shunts (for example, during transition or in patients with 
congenital structural heart defects). Bedside continuous and 
non-invasive measurement methods are preferred, although they 
have the disadvantage of being less accurate and precise.
Non-Invasive CO Measurement Methods Applicable 
in Newborn Infants
Neonatologist Performed Echocardiography (NPE)
Neonatologist Performed Echocardiography is currently the most 
used non-invasive technique to estimate CO in neonatal intensive 
care. NPE provides extensive real-time hemodynamic informa-
tion regarding intra- and extra-cardiac shunts, myocardial 
(dys)function, systemic and PBF, and volume changes (66, 67). 
Spectral analysis of the Doppler shift will produce time-velocity 
waveforms. The velocity-time integral (VTI) is known as stroke 
distance, which is the distance that a column of blood will travel 
during a defined time period. SV can then be calculated using the 
CSA of the vessel or outflow tract of interest (SV = VTI × CSA). 
When SV is multiplied by the HR CO is calculated. The major 
difficulty is the estimation of the vessel dimensions for the cal-
culation of the CSA as CSA = π(D/2)2 with D the diameter of a 
vessel. A small error in measuring the diameter of the aorta will 
result in a large error for the estimation of SV and, therefore, CO, 
since the error is squared. Moreover, the incorrect assumption is 
made that the vessels are perfectly round in shape. Furthermore, 
in the presence of a patent ductus arteriosus with transductal left-
to-right shunting, right ventricular output (RVO), and not LVO 
equals SBF as RVO reflects right ventricular input and, therefore, 
systemic VR. Some confounding by left-to-right shunting across 
the PFO with an increase in RVO and subsequent overestimation 
of SBF is, however, possible (66). Measurement of superior vena 
cava flow—which also reflects cerebral blood flow—can be used as 
a surrogate for SBF, although only from the upper body part (68). 
Current recommendations and guidelines to treat hypotension 
include NPE to target cardiovascular support and monitor the 
response of the initiated therapy (69, 70). The method is bedside 
available and non-invasive. Despite all these advantages, NPE has 
potential pitfalls: measurements are not continuous, intensive 
training and continuous practice is required, and even in capable 
hands a significant intra- and inter-observer variability has been 
observed (71). This inaccuracy is caused by the angle of insona-
tion leading to errors in VTI and—as already mentioned—the 
estimation of the CSA. Training guidelines have been developed 
to ensure the optimal use of NPE (72). The clinical gold standard 
to measure CO in adults is the pulmonary artery catheter. As 
this method is not feasible in neonates, 2D-echocardiography is 
regarded as best practice in neonates and used for most validation 
studies with advanced hemodynamic monitoring devices, despite 
its relatively high error percentage of ±30%.
Transcutaneous Doppler Technique
The transcutaneous Doppler technique is used in the ultra-
sonic CO monitor (USCOM®, USCOM Ltd., Sydney, NSW, 
Australia)—a continuous wave Doppler device that is less 
expensive than conventional ultrasound. USCOM® is designed 
for rapid, non-invasive measurement of CO using a probe located 
at either the sternal notch (aortic valve; LVO) or parasternal (pul-
monary valve; RVO). CO is calculated from the measured blood 
flow velocity profile across the aortic or pulmonary valve. The 
monitor displays the VTI without visible 2D-information of the 
outflow tract. Results in neonates are conflicting: despite the good 
agreement found between RVO measurements by echocardiogra-
phy and USCOM® in preterm infants, precision was lacking (73). 
Other studies in (near) term newborns comparing CO estimates 
by USCOM® and transthoracic echocardiography showed poor 
accuracy as well as low reliability with differences in RVO and 
LVO, irrespective of the presence of a PDA (74, 75). The authors 
speculated that these differences were caused by a systemic error 
in the calculation of the CSA of aortic and pulmonary values or 
by the turbulent flow in the pulmonary artery with erroneously 
high values of RVO. Although new users can be trained quickly, 
there remains a high inter-user variability. The limitations of the 
methods are mainly due to the use of normograms based on the 
patient’s height, weight, and age for estimation of the valve CSA. 
As absolute measurements of echocardiography and USCOM® 
are not interchangeable at this time, the latter might be used in 
clinical practice as a trend monitor to detect CO changes.
Thoracic Electrical Bioimpedance
Thoracic electrical bioimpedance (TEB) is a non-invasive, easy 
applicable (four disposable surface electrodes), and continuous 
CO measurement method for newborns. TEB is based on imped-
ance cardiographic technology and uses changes in thoracic 
electrical impedance caused by the cardiac cycle: the difference 
in measured voltage—produced by a small electrical current—
caused by the change in alignment of red blood cells in the aorta 
during systole respective to diastole is used to calculate SV and 
CO. SV is calculated using algorithms estimating flow time, mean 
velocity index, and body mass. CO measurements by TEB might 
be influenced by the position of the surface electrodes, changes 
in tissue water content (pulmonary edema, pleural effusion), 
and alterations in HR or patient movement. Methods of TEB 
differ in which component of bioimpedance is utilized to cre-
ate the impedance cardiogram, and in the interpretation of the 
waveform. Examples are Electrical Cardiometry (EC; ICON®, 
Ausculon®, Osypka Medical GmbH, Berlin, Germany) and the 
bioreactance method (Starlin®, NICOM®; Cheetah Medical 
Inc., Vancouver, WA, USA), where the first method analyzes 
the changes in signal amplitude and the latter the changes in 
phase shift of thoracic impedance during the cardiac cycle. 
Weisz et al. found that CO measurements using NICOM® were 
feasible in neonates (GA 31–41weeks) with acceptable accuracy 
and precision compared to transthoracic echocardiography, but 
that LVO was systemically underestimated (76). They also found 
that in unstable extremely preterm infants after PDA-ligation, 
NICOM® may be used merely as trend monitoring due to a large 
imprecision and an increasing inaccuracy over time compared 
to echocardiography (77). Based on preliminary data for CO 
estimates by EC in (pre)term newborns, body mass calculations 
for neonates have been adjusted in the current algorithm. Noori 
et al. found an acceptable agreement and precision between CO 
values measured by EC, and LVO measured by transthoracic 
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echocardiography in healthy term neonates during transition 
(78). Grollmuss et al. presented similar results in 24 term neo-
nates until 72 h after an arterial switch operation (79). Boet and 
colleagues showed good correlation with echocardiography for 
the measurements of SV and CO with EC in hemodynamically 
stable preterm infants, although there was a trend to overestima-
tion at highest values (80). Torigoe et al. also found good agree-
ment between CO measurements using electrical cardiometry 
and transthoracic echocardiography in patients with no or small 
PDA, but in patients with hemodynamically significant PDA 
CO measurement by EC seemed less reliable (81). The value of 
EC in assessing changes in CO in critically ill preterm and term 
infants in response to initiation of cardiovascular supportive 
care is not yet investigated. Since all studies compared TEB with 
transthoracic echocardiography for estimating CO, it must be 
emphasized that the latter is not the preferred gold standard 
reference technology. In our opinion TEB can be used as a trend 
monitor over time in clinical practice.
Invasive CO Measurement Methods
Indicator Dilution Techniques
The current use of invasive CO measurement methods is limited 
in neonatal intensive care. Indicator dilution techniques estimate 
CO based on changes of indicator concentration over time fol-
lowing an intravenous injection. Transpulmonary thermodilu-
tion (TPTD; PiCCO®, Pulsion Medical Systems, Feldkirchen, 
Germany) using ice-cold saline as an indicator is regarded as 
the clinical gold standard for estimating CO in children. As a 
dedicated thermistor-tipped arterial 3-French catheter needs to 
be inserted, this technology is not feasible in neonates weighing 
less than 3.5 kg.
Transpulmonary ultrasound dilution (TPUD; COstatus®, 
Transonic Systems Inc., Ithaca, NY, USA) might have potential 
for future use in (preterm) newborns (>0.6 kg). CO is calculated 
from a dilution curve that is obtained by the decrease in ultrasound 
velocity of the blood after injection of the indicator (isotonic 
saline heated to body temperature). The system uses an extracor-
poreal loop which can be connected in between any indwelling 
central venous and arterial catheter. The use of a non-toxic, low 
volume indicator (0.5–1 ml/kg) on body temperature makes the 
method attractive even for the smallest infants. TPUD provides 
information on CO, hemodynamic volumes, and the presence 
and magnitude of shunts (82). Validation studies in newborn 
lambs show good agreement and precision between CO measured 
by TPUD and ultrasonic flow probes (83). Measurements have 
shown to be reliable in animals with a left-to-right transductal 
shunt, respiratory distress syndrome, during shock and after fluid 
replacement (84–86). A possible limitation could be the risk of 
fluid overload after multiple injections of indicator. The method 
is feasible in infants and children (87–89). Clinical studies in 
neonates are in progress and reports in newborns/infants seem 
promising (90, 91).
Arterial Pulse Contour Analysis (APCA)
Arterial pulse contour analysis continuously measures CO by 
translating the arterial pressure waves into a beat-to-beat SV 
(92). Several APCA systems are available for adults, all with 
their own specific algorithms and assumptions regarding 
aortic impedance (resistance, compliance, and inductance) to 
translate the pressure wave form into SV. None of them are 
designed to take into account the specific vascular properties 
of children and infants. Reliability and accuracy (in children) 
is further hampered by changes in compliance and vasomotor 
tone, irregular HRs, movement artifacts, damped wave forms 
as a result of small catheters. The arterial pulse contour is also 
dependent on the site of registration. Pulse contour analysis 
can be used to detect changes in CO, especially when measure-
ments are calibrated on a regular basis with another (semi-)
invasive technology, such as the TPTD or TPUD. Studies in 
infants and children are conflicting, lack accuracy and are 
not convincing (93–95). Studies in neonates have not been 
published.
Stroke volume estimates (and in addition CO) can also be 
obtained by photoelectric plethysmography as a non-invasive con-
tinuous finger arterial pressure measurement method in adults. 
The Nexfin device® (Edwards Lifesciences Corporation (BMeye), 
Irvine, CA, USA) has an incorporated arterial pulse contour CO 
monitor device that is applicable to the arterial waveform from 
the finger artery. At present only finger cuffs for adults and older 
children are available. The method seems feasible for blood pres-
sure measurements in children, but further technical develop-
ment is required for future CO measurement use in children and 
neonates as aforementioned (96).
Assessment of Preload and volume 
Responsiveness—is it Possible?
Treatment of hypotension and circulatory failure in (preterm) 
newborns is challenging as interventions may be helpful, but also 
harmful. The most common first line treatment of hypotension 
is the administration of a fluid bolus, although this is associated 
with adverse cardiovascular effects or outcome when given 
unnecessarily (97). A fluid bolus will only result in an increase of 
preload and SV when the myocardium functions at the steep part 
of the FS curve (see also Figure 3). Fluid responsiveness is defined 
as an increase in CO or SV of more than 10–15% after volume 
expansion. Fluid overload (including pulmonary edema) without 
a resultant increase in CO will occur if fluid is administered when 
the patient is positioned on the flat part of the FS curve. Therefore, 
it would be desirable if we could predict fluid responsiveness in 
our neonatal population. Some interesting studies in adult and 
pediatric patients might guide us to new methods for future 
neonatal use.
Static variables—based on single observations in time—
include HR, arterial blood pressure, central venous pressure 
(CVP), and end-diastolic volume estimates. Several studies in 
adults, children, and infants (>3 kg) have shown that CVP is a 
poor predictor of preload as it is influenced by multiple factors, 
such as right ventricular compliance, intra-abdominal pressure, 
and respiratory pressures (98). Although no neonatal studies 
have been published, CVP seems of limited value to predict fluid 
responsiveness in newborn infants.
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Collapsibility of the IVC and LV end-diastolic volume meas-
ured by transthoracic echocardiography are often used to decide 
whether or not to give a fluid bolus. In pediatric studies, the latter 
parameter also failed to demonstrate an adequate predictive value, 
whereas the results for IVC variations are contradictory (99, 100).
The TPUD method can be used to estimate several hemody-
namic volumes, such as total end-diastolic volume, but evidence 
on its value for preload assessment is still lacking (86).
Measuring Pmsf might be useful as it provides not only a 
quantitative measurement of the filling status, but also repre-
sents an estimate of the venous vascular resistance when simul-
taneously measured with CVP. Also, changes in Pmsf reflect 
changes in stressed circulatory volume. Pmsf—the pressure of 
equilibrium during a circulatory arrest—can be estimated at the 
bedside by different methods in ventilated adults, for example, 
the stop-flow method. This method estimates the arterial–
venous equilibrium pressure (Pmsf) after proximal occlusion 
(stop-flow) of an extremity equipped with both an arterial and 
venous cannula. This is realized by inflating a cuff to a pressure 
above the systolic blood pressure for 30  s (101). Despite its 
invasiveness—requirement of a peripheral arterial catheter and 
preferably a peripheral intravenous access in the same extremity 
to measure venous pressure—the stop-flow method might be 
applicable in (ventilated) newborns. However, the usefulness 
of measuring Pmsf to predict fluid responsiveness and guide 
hemodynamic therapy might be limited due to its static nature 
and has still to be proven.
Dynamic parameters as described below are based on the 
variation in preload and SV secondary to cardiopulmonary 
interactions, for example, during positive pressure ventilation. 
Cyclic changes in SV between inspiration and expiration are 
largest when the patients’ functions on the steep part of the FS 
curve. This variation is also observed downstream as variable 
aortic blood flow, arterial blood pressure, or plethysmographic 
waveform amplitude. Different dynamic variables derived from 
arterial blood pressure variations have a better predictive value in 
adults than in children (98). The method is not yet validated in 
ventilated neonates, but its use is questionable as it is influenced 
by physiological factors (higher thoracic and arterial compli-
ance and low tidal volumes compared to adults) and low HR/
respiratory rate ratio’s (physiological aliasing), hampering the 
use of arterial blood pressure variations for the prediction of 
fluid responsiveness in newborn infants (102). The non-invasive 
plethysmograph variability index PVI is obtained from the pulse 
oximeter and reflects the dynamic change in perfusion index 
(PI) that occurs during at least one respiratory cycle (103). PI is 
defined as the percentage ratio between the pulsatile and nonpul-
satile infrared signal. The pulsatile signal is mainly determined 
by arterial blood flow and the nonpulsatile signal by bone, tissue, 
pigments, nonpulsatile (venous and capillary) blood, and skin. 
Studies in children are inconclusive regarding the use of PVI to 
predict fluid responsiveness. Bagci et al. evaluated the technique 
in hypotensive neonates during surgery and suggested that PVI 
may predict fluid responsiveness (104). However, as measure-
ments are subject to the same factors that influence arterial blood 
pressure variations, its value for predicting fluid responsiveness 
is limited.
Assessment of Organ Perfusion and 
Oxygen Delivery
As it is not only oxygen delivery that is important for preservation 
of tissue integrity, but also merely the balance between oxygen 
delivery and consumption on both a global and regional level, 
additional monitoring systems are required to detect early 
changes in regional blood flow, and oxygen consumption and 
extraction. Clinical parameters in combination with additional 
blood gas analysis and measurement of lactate levels are mainly 
used to assess poor perfusion in neonates. The predictive value for 
circulatory failure of most of these (individual) indicators is rather 
limited, although changes over time or a combination of parame-
ters may be more informative (105). As previously stated, changes 
in central venous oxygen saturation can be used as a surrogate 
for changes in mixed venous oxygen saturation when interpreted 
with caution. Although there is no linear relationship between 
ScvO2 and CO (children) and no correlation between ScvO2 and 
SBF in preterm infants (106, 107), there is some evidence that 
early goal-directed therapy using intermittent ScvO2 monitoring 
seems to reduce mortality rates and improve organ dysfunction 
in pediatric patients with septic shock (108, 109). In guidelines 
for the management of neonatal (catecholamine-resistant) septic 
shock, it is also advised to target repetitively ScvO2 values >70% 
(70). In contrast, three recent trials based on early goal-directed 
therapy showed that additional continuous ScvO2 monitoring did 
not improve outcome in septic adult patients who were identified 
early and received intravenous antibiotics and fluid resuscitation 
(110–112).
For the assessment of peripheral perfusion and microcircula-
tion, a number of methods are currently available. Laser Doppler 
flowmetry uses a low-intensity laser light to measure the flow 
velocity of blood cells in the skin circulation. It has been shown 
that the neonatal microcirculation is subject to developmental 
changes after birth and relates to clinical illness severity scores in 
preterm infants. Although non-invasive and feasible in neonates, 
the method had some considerable (methodological) limitations 
(signal processing limitations, instrument calibration problems, 
motion artifacts, and effects of probe pressure) that prevent its 
clinical use at this moment (113).
Orthogonal polarization spectral (OPS), sidestream darkfield 
(SDF) imaging, and its technical successor the incident dark field 
imaging are other technologies to assess microcirculation by 
using light waves within the hemoglobin absorption spectrum. 
Quantitative measurement of the diameter of vessels, the velocity 
of red blood cells, and functional capillary density are made using 
buccal or skin measurements. OPS and SDF seem to be valuable 
clinical tools for the estimation of tissue perfusion in healthy and 
critically ill newborns (114, 115). However, temperature, hemo-
globin levels, and the use of vasopressors can influence the results. 
Although measurements can be performed non-invasively at the 
bedside, results are not yet instantly available as calculations 
have to been performed offline and are rather time-consuming. 
Automated analysis will certainly facilitate future use.
Near infrared spectroscopy (NIRS) estimates regional blood 
flow, regional tissue oxygenation and—when simultaneously 
measured with arterial oxygen saturation—also fractional tissue 
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oxygenation extraction, depending on the used NIRS technique. 
The technique uses infrared light to estimate tissue concentra-
tions of oxy- and deoxyhemoglobin in real time. The method is 
non-invasive, provides continuous real-time information and is 
easily applicable even in the smallest preterm infants. Knowledge 
of regional (cerebral) blood flow and tissue oxygen extraction 
is useful during transition, in the phase of compensated shock 
with vital organ assignment (especially in the preterm, where 
the forebrain vasculature does not function as a high-priority 
structure shortly after birth as suggested by some) and during 
periods of hypotension with possible loss of cerebral autoregula-
tion, all events with potential risk for adverse outcome. Although 
the technique is predominantly limited to clinical research, its 
clinical use is increasing. Observational studies in neonates 
evaluated the applicability of NIRS in the NICU (monitoring 
cerebral/splanchnic/renal autoregulation during interventions, 
administration of cardiovascular drugs et cetera) and beyond 
(intra-operatively, in the delivery room) and results are promising 
(116). However, when interpreting result users have to consider 
several limitations: (1) validation is lacking, (2) accuracy and 
precision are questionable, (3) probe bias is considerable, (4) dif-
ferent NIRS-methods use different mathematical models, signal 
processing, and data requirements, and (5) some assumptions 
have to be made (stable hemoglobin concentration, venous/arte-
rial blood ratios, and cerebral metabolic demands are required) to 
use oxygen extraction as a surrogate for blood flow. At present, the 
large diversity and heterogenity of the NIRS studies make it dif-
ficult to draw conclusions about the clinical benefits of (cerebral) 
monitoring with NIRS (117, 118). Interventional studies evaluat-
ing the use of NIRS are in progress. Results of the SafeBoosC 
trial show that episodes of cerebral hypoxia and hyperoxia were 
significantly reduced in preterm infants monitored by NIRS and 
treated according to a dedicated guideline compared to controls, 
however, without any differences in short-term outcome (119).
CONCLUSiON
The neonatal circulation is unique and distinguishes itself 
from the circulation later on in life in many ways. Knowledge 
of the immature cardiac function during transition is essential 
to understand the specific pathologies and to target therapeu-
tic interventions. Adequate and objective assessment of the 
systemic and peripheral circulation is, therefore, necessary, 
preferably in a non-invasive and continuous way. Technical 
advances have broadened the arsenal of monitoring systems 
over the past years, and although some of them might have 
potential for neonatal use in the near future, most of the cur-
rent hemodynamic monitoring systems are not yet applicable 
in the vulnerable newborn. Further technical improvement 
is, therefore, required. It is important to recognize the limita-
tions of the monitoring system used. And above all: monitor-
ing itself—even if accurate or complete—will not improve 
outcome by itself, but rather by appropriate therapeutic 
interventions guided by adequate interpretation of the data 
obtained (120).
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